openPR Logo
Press release

HIV Diagnosis Market is Predicted to Expand by 2025 with Growing CAGR Value

04-25-2019 08:59 AM CET | Health & Medicine

Press release from: Allied Market Research

HIV Diagnosis Market

HIV Diagnosis Market

The diagnosis of HIV detects the presence of the human immunodeficiency virus (HIV), which causes the acquired immunodeficiency syndrome (AIDS). This is done by carrying out certain tests in serum, saliva, or urine samples. These tests may detect antibodies, antigens, or RNA. The increasing awareness about HIV, confidentiality of the test, and appropriate counseling increases the demand for this process.

Download Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2815

The major factors that contribute to the growth of the global HIV diagnosis market includes the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions & blood donations that cause infections, which lead to HIV, benefits offered by point-of-care instruments & kits, technological advancements, and increasing government initiatives. However, high costs of Nucleic Acid Testing (NAT) and lack of mandates for NAT in developing countries are the major factors that restrain the growth of this market. Recent advancements of simple rapid assays with visual testing and easy handling home sample collection techniques that can be used by health care workers and consumers at home has carved ways to expand this market.

This market has been classified by technology into antibody tests, viral load tests, CD4 tests, and early infant diagnosis tests. On the basis of application it has been segmented into diagnostic laboratories, home care settings, hospitals, and blood banks. Geographically, the market has been divided into North America, Europe, Asia-Pacific and LAMEA.

The key players in the HIV diagnosis market profiled in this report are Siemens-AG, Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Thermo-Fisher Scientific Inc., Merck & Co., Becton-Dickinson and Company, Hologic, Inc., Alere Inc., and Bio-Rad Laboratories (U.S.).

Report Key Benefits:

• Market analysis for the global HIV diagnosis market, with region-specific assessments and competition analysis on a global and regional scale.
• It provides extensive information about the current and upcoming trends in the global HIV diagnosis market from 2016 to 2023, which helps find opportunities in this field.
• Market definition along with the identification of key drivers and restraints.
• Identification of factors instrumental in changing the market scenario, raising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
• Extensively researched competitive landscape section with profiles of major companies along with their market shares.
• A wide-ranging knowledge & insights about the major players in this industry, along with the key strategies adopted by them to sustain and grow in the studied market.
• Insights on major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

Hiv Diagnosis Market Key Segments:

By Technology

• Antibody Tests

o HIV-1 Screening Tests
o HIV-1 Confirmatory Tests
o HIV-2 & Group O Diagnostic Tests

• Viral Load Tests
• CD4 Tests
• Tests for Early Infant Diagnosis
• Tests for Viral Identification

By Application

• Diagnostic laboratories
• Hospitals
• Blood Banks
• Home care settings
• Others

By Region

• North America
• Europe
• Asia-Pacific
• LAMEA

For More Info on this Report, Visit @ https://www.alliedmarketresearch.com/hiv-diagnosis-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Diagnosis Market is Predicted to Expand by 2025 with Growing CAGR Value here

News-ID: 1717367 • Views: 219

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral